Knockdown of SNHG16 suppresses the proliferation and induces the apoptosis of leukemia cells via miR‑193a‑5p/CDK8

Piao,Meihua; Zhang,Li

doi:10.3892/ijmm.2020.4671

Knockdown of SNHG16 suppresses the proliferation and induces the apoptosis of leukemia cells via miR‑193a‑5p/CDK8

Authors:
- Meihua Piao
- Li Zhang
View Affiliations

Affiliations: Clinical Laboratory, Yanbian University Hospital (Yanbian Hospital), Yanji, Jilin 133000, P.R. China, Department of Neonatology, Weinan Maternal and Child Health Hospital, Weinan, Shaanxi 714000, P.R. China
Published online on: July 8, 2020 https://doi.org/10.3892/ijmm.2020.4671
Pages: 1175-1185
Copyright: © Piao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Although small nucleolar RNA host gene 16 (SNHG16) is known to exhibit auxo‑action in certain types of tumor, its role in leukemia remains unclear. The present study analyzed the role and mechanisms of action of SNHG16 in leukemia cells in order to identify therapeutic targets for this disease. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was performed to determine SNHG16 expression in human leukemia cell lines. Using TargetScan 7.2 and dual‑luciferase reporter assay, the target genes of SNHG16 were verified. Following the downregulation of the expression of SNHG16 or its target genes, Cell Counting kit‑8 (CCK‑8) assay was performed to examine the viability of the leukemia cells. In addition, flow cytometry was performed to analyze the cell apoptotic rates, and colony formation assays were used to determine the cell proliferative ability. RT‑qPCR and western blot analysis were used to determine the association between SNHG16 and its target genes. SNHG16 was found to be abnormally highly expressed in acute myeloblastic leukemia cell lines, the knockdown of which weakened the viability of the leukemia cells, suppressed cell proliferation and promoted cell apoptosis. miR‑193a‑5p could bind to SNHG16, and its target gene was CDK8. Moreover, the expression of miR‑193a‑5p increased with the decrease in SNHG16 expression, while the inhibition of miR‑193a‑5p promoted the expression of CDK8. The downregulation of miR‑193a‑5p enhanced the viability of the leukemia cells, accelerated cell cloning and reduced cell apoptosis, which was completely opposite to the effects observed with the silencing of CDK8. The knockdown of SNHG16 suppressed the viability of the leukemia cells, suppressed cell proliferation, and induced cell apoptosis by regulating miR‑193a‑5p/CDK8. Thus, SNHG16 may prove to be a potential therapeutic target for the treatment of leukemia.

View Figures

View References

1	Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, Kennedy JA, Schimmer AD, Schuh AC, Yee KW, et al: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 506:328–333. 2014. View Article : Google Scholar : PubMed/NCBI
2	Eguchi-Ishimae M and Eguchi M: Leukemia. Gan To Kagaku Ryoho. 43:1341–1345. 2016.In Japanese. PubMed/NCBI
3	Nikkila A, Erme S, Arvela H, Holmgren O, Raitanen J, Lohi O and Auvinen A: Background radiation and childhood leukemia: A nationwide register-based case-control study. Int J Cancer. 139:1975–1982. 2016. View Article : Google Scholar : PubMed/NCBI
4	Brown N, Finnon R, Manning G, Bouffler S and Badie C: Influence of radiation quality on mouse chromosome 2 deletions in radiation-induced acute myeloid leukaemia. Mutat Res Genet Toxicol Environ Mutagen. 793:48–54. 2015. View Article : Google Scholar : PubMed/NCBI
5	Shahrabi S, Khodadi E, Saba F, Shahjahani M and Saki N: Sex chromosome changes in leukemia: Cytogenetics and molecular aspects. Hematology. 23:139–147. 2018. View Article : Google Scholar
6	Yamaguchi H: Gene mutations in acute myeloid leukemia. Rinsho Ketsueki. 57:2535–2542. 2016.
7	Fernando TR, Rodriguez-Malave NI, Waters EV, Yan W, Casero D, Basso G, Pigazzi M and Rao DS: lncRNA expression discriminates karyotype and predicts survival in B-Lymphoblastic leukemia. Mol Cancer Res. 13:839–851. 2015. View Article : Google Scholar : PubMed/NCBI
8	Pan JQ, Zhang YQ, Wang JH, Xu P and Wang W: lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia. Int J Mol Med. 39:663–671. 2017. View Article : Google Scholar : PubMed/NCBI
9	Lammens T, Durinck K, Wallaert A, Speleman F and Van Vlierberghe P: Long non-coding RNAs in leukemia: Biology and clinical impact. Curr Opin Hematol. 24:353–358. 2017. View Article : Google Scholar : PubMed/NCBI
10	Lee JT: Epigenetic regulation by long noncoding RNAs. Science. 338:1435–1439. 2012. View Article : Google Scholar : PubMed/NCBI
11	St Laurent G, Wahlestedt C and Kapranov P: The Landscape of long noncoding RNA classification. Trends Genet. 31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI
12	Chen S, Liang H, Yang H, Zhou K, Xu L, Liu J, Lai B, Song L, Luo H, Peng J, et al: Long non-coding RNAs: The novel diagnostic biomarkers for leukemia. Environ Toxicol Pharmacol. 55:81–86. 2017. View Article : Google Scholar : PubMed/NCBI
13	Akhade VS, Pal D and Kanduri C: Long noncoding RNA: Genome organization and mechanism of action. Adv Exp Med Biol. 1008:47–74. 2017. View Article : Google Scholar : PubMed/NCBI
14	Dai M, Li S and Qin X: Colorectal neoplasia differentially expressed: A long noncoding RNA with an imperative role in cancer. Onco Targets Ther. 11:3755–3763. 2018. View Article : Google Scholar : PubMed/NCBI
15	Peng W, Fan H, Wu G, Wu J and Feng J: Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity. Clin Exp Med. 16:177–182. 2016. View Article : Google Scholar
16	Meng H, Han L, Hong C, Ding J and Huang Q: Aberrant lncRNA expression in multiple myeloma. Oncol Res. 26:809–816. 2018. View Article : Google Scholar
17	Zhu H, Zeng Y, Zhou CC and Ye W: SNHG16/miR-216-5p/ZEB1 signal pathway contributes to the tumorigenesis of cervical cancer cells. Arch Biochem Biophys. 637:1–8. 2018. View Article : Google Scholar
18	Cao X, Xu J and Yue D: lncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancer. Cancer Gene Ther. 25:10–17. 2018. View Article : Google Scholar
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
20	Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, et al: Landscape of transcription in human cells. Nature. 489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
21	Peng WX, Koirala P and Mo YY: lncRNA-mediated regulation of cell signaling in cancer. Oncogene. 36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
22	Yu M, Ohira M, Li Y, Niizuma H, Oo ML, Zhu Y, Ozaki T, Isogai E, Nakamura Y, Koda T, et al: High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma. Int J Oncol. 34:931–938. 2009.PubMed/NCBI
23	Christensen LL, True K, Hamilton MP, Nielsen MM, Damas ND, Damgaard CK, Ongen H, Dermitzakis E, Bramsen JB, Pedersen JS, et al: SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism. Mol Oncol. 10:1266–1282. 2016. View Article : Google Scholar : PubMed/NCBI
24	Cai C, Huo Q, Wang X, Chen B and Yang Q: SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5. Biochem Biophys Res Commun. 485:272–278. 2017. View Article : Google Scholar : PubMed/NCBI
25	Thomson DW and Dinger ME: Endogenous microRNA sponges: Evidence and controversy. Nat Rev Genet. 17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
26	Bianchi E, Ruberti S, Rontauroli S, Guglielmelli P, Salati S, Rossi C, Zini R, Tagliafico E, Vannucchi AM and Manfredini R: Role of miR-34a-5p in hematopoietic progenitor cells proliferation and fate decision: Novel insights into the pathogenesis of primary myelofibrosis. Int J Mol Sci. 18:1452017. View Article : Google Scholar :
27	Lu YF, Cai XL, Li ZZ, Lv J, Xiang YA, Chen JJ, Chen WJ, Sun WY, Liu XM and Chen JB: lncRNA SNHG16 functions as an oncogene by sponging miR-4518 and up-regulating PRMT5 expression in glioma. Cell Physiol Biochem. 45:1975–1985. 2018. View Article : Google Scholar : PubMed/NCBI
28	Chou NH, Lo YH, Wang KC, Kang CH, Tsai CY and Tsai KW: miR-193a-5p and -3p play a distinct role in gastric cancer: miR-193a-3p suppresses gastric cancer cell growth by targeting ETS1 and CCND1. Anticancer Res. 38:3309–3318. 2018. View Article : Google Scholar : PubMed/NCBI
29	Zhang P, Ji DB, Han HB, Shi YF, Du CZ and Gu J: Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer. World J Gastroenterol. 20:12241–12248. 2014. View Article : Google Scholar : PubMed/NCBI
30	Wang JT and Wang ZH: Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 22:7233–7239. 2018.PubMed/NCBI
31	Yu T, Li J, Yan M, Liu L, Lin H, Zhao F, Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway. Oncogene. 34:413–423. 2015. View Article : Google Scholar
32	Witalisz-Siepracka A, Gotthardt D, Prchal-Murphy M, Didara Z, Menzl I, Prinz D, Edlinger L, Putz EM and Sexl V: NK cell-specific CDK8 deletion enhances antitumor responses. Cancer Immunol Res. 6:458–466. 2018. View Article : Google Scholar : PubMed/NCBI
33	Yergiyev O, Garib G, Schoedel K, Palekar A, Bartlett D and Rao UNM: CDK8 expression in extrauterine leiomyo-sarcoma correlates with tumor stage and progression. Appl Immunohistochem Mol Morphol. 26:161–164. 2018.